UNICRISTIN 1MG ING

About

Unicristin 1mg Injection is a potent vinca alkaloid chemotherapy agent, naturally derived from the periwinkle plant, widely employed in the treatment of various hematological malignancies and solid tumors. Its precise mechanism of action involves binding to tubulin, a crucial protein subunit that forms microtubules. By disrupting the dynamic assembly and disassembly of microtubules, Unicristin effectively inhibits the formation of the mitotic spindle, which is essential for cell division. This interference arrests cancer cells in the metaphase of mitosis, preventing their proliferation and ultimately leading to programmed cell death (apoptosis). As a cell cycle-specific agent, its activity is most pronounced during the M-phase. Unicristin is frequently incorporated as a key component in multi-drug combination chemotherapy regimens, valued for its distinct mechanism of action and relatively lower myelosuppression compared to many other cytotoxic agents.

Uses

• Treatment of acute lymphoblastic leukemia (ALL).
• Management of Hodgkin's and non-Hodgkin's lymphoma.
• Therapy for Wilms' tumor.
• Used in neuroblastoma.

Directions For Use

Administered intravenously by a healthcare professional. It must be given slowly and never intrathecally.

Benefits

• Effective against a wide range of cancers.
• Disrupts cancer cell division.
• Often used in curative combination regimens.
• Relatively low myelosuppression.
• Can induce remission in various leukemias and lymphomas.
• Important component of pediatric oncology protocols.

Side Effects

• Peripheral neuropathy (dose-limiting)
• Constipation
• Paralytic ileus
• Jaw pain
• Alopecia (hair loss)
• Hyponatremia (SIADH)
• Muscle weakness
• Hoarseness
• Foot drop
• Paresthesias
• Nausea
• Vomiting

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but general moderation is advised.
• Pregnancy - Unicristin is teratogenic and contraindicated in pregnancy due to potential fetal harm. Effective contraception is essential.
• Breastfeeding - Breastfeeding is contraindicated during Unicristin therapy due to the risk of serious adverse effects in the infant.
• Liver - Use with extreme caution in patients with liver impairment; dose reduction is often necessary due to impaired metabolism.
• Kidney - No specific dose adjustment is typically required for kidney impairment, as it is primarily metabolized by the liver.
• Lung - Rare but serious pulmonary toxicity can occur; monitor for respiratory symptoms, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.